Global Natural Killer Cell Therapeutics Market Growth 2018-2023

Global Natural Killer Cell Therapeutics Market Growth 2018-2023

Category

Pharmaceuticals

Published Date

22nd Oct 2018

Pages

136

Choose License

Final Price

This report covers the present scenario (with the base year being 2017) and the growth prospects of global Natural Killer (NK) Cell Therapeutics market for 2018-2023.

Natural killer cells are a type of cytotoxic lymphocyte, which is a component of the innate immune system.
Over the next five years, this report projects that Natural Killer (NK) Cell Therapeutics will register a xx% CAGR in terms of revenue, reach US$ xx million by 2023, from US$ xx million in 2017.

This report presents a comprehensive overview, market shares, and growth opportunities of Natural Killer (NK) Cell Therapeutics market by product type, application, key manufacturers and key regions.

To calculate the market size, this report considers value and volume generated from the sales of the following segments:

Segmentation by product type:
Mogamulizumab
Lorvotuzumab Mertansine
Others
Segmentation by application:
Cancer
Cardiovascular Diseases
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report:
Chipscreen Biosciences (China)
Affimed NV (Netherlands)
Altor BioScience Corporation (USA)
Innate Pharma SA (France)
Takeda Pharmaceutical (Japan)
Sorrento Therapeutics Inc. (USA)
NantKwest Inc. (USA)
Bristol-Myers Squibb (USA)
NKT Therapeutics (USA)

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Natural Killer (NK) Cell Therapeutics consumption (value & volume) by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
To understand the structure of Natural Killer (NK) Cell Therapeutics market by identifying its various subsegments.
Focuses on the key global Natural Killer (NK) Cell Therapeutics manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Natural Killer (NK) Cell Therapeutics with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Natural Killer (NK) Cell Therapeutics submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents

2018-2023 Global Natural Killer (NK) Cell Therapeutics Consumption Market Report

1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Natural Killer (NK) Cell Therapeutics Consumption 2013-2023
2.1.2 Natural Killer (NK) Cell Therapeutics Consumption CAGR by Region
2.2 Natural Killer (NK) Cell Therapeutics Segment by Type
2.2.1 Mogamulizumab
2.2.2 Lorvotuzumab Mertansine
2.2.3 Others
2.3 Natural Killer (NK) Cell Therapeutics Consumption by Type
2.3.1 Global Natural Killer (NK) Cell Therapeutics Consumption Market Share by Type (2013-2018)
2.3.2 Global Natural Killer (NK) Cell Therapeutics Revenue and Market Share by Type (2013-2018)
2.3.3 Global Natural Killer (NK) Cell Therapeutics Sale Price by Type (2013-2018)
2.4 Natural Killer (NK) Cell Therapeutics Segment by Application
2.4.1 Cancer
2.4.2 Cardiovascular Diseases
2.4.3 Others
2.5 Natural Killer (NK) Cell Therapeutics Consumption by Application
2.5.1 Global Natural Killer (NK) Cell Therapeutics Consumption Market Share by Application (2013-2018)
2.5.2 Global Natural Killer (NK) Cell Therapeutics Value and Market Share by Application (2013-2018)
2.5.3 Global Natural Killer (NK) Cell Therapeutics Sale Price by Application (2013-2018)

3 Global Natural Killer (NK) Cell Therapeutics by Players
3.1 Global Natural Killer (NK) Cell Therapeutics Sales Market Share by Players
3.1.1 Global Natural Killer (NK) Cell Therapeutics Sales by Players (2016-2018)
3.1.2 Global Natural Killer (NK) Cell Therapeutics Sales Market Share by Players (2016-2018)
3.2 Global Natural Killer (NK) Cell Therapeutics Revenue Market Share by Players
3.2.1 Global Natural Killer (NK) Cell Therapeutics Revenue by Players (2016-2018)
3.2.2 Global Natural Killer (NK) Cell Therapeutics Revenue Market Share by Players (2016-2018)
3.3 Global Natural Killer (NK) Cell Therapeutics Sale Price by Players
3.4 Global Natural Killer (NK) Cell Therapeutics Manufacturing Base Distribution, Sales Area, Product Types by Players
3.4.1 Global Natural Killer (NK) Cell Therapeutics Manufacturing Base Distribution and Sales Area by Players
3.4.2 Players Natural Killer (NK) Cell Therapeutics Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Natural Killer (NK) Cell Therapeutics by Regions
4.1 Natural Killer (NK) Cell Therapeutics by Regions
4.1.1 Global Natural Killer (NK) Cell Therapeutics Consumption by Regions
4.1.2 Global Natural Killer (NK) Cell Therapeutics Value by Regions
4.2 Americas Natural Killer (NK) Cell Therapeutics Consumption Growth
4.3 APAC Natural Killer (NK) Cell Therapeutics Consumption Growth
4.4 Europe Natural Killer (NK) Cell Therapeutics Consumption Growth
4.5 Middle East & Africa Natural Killer (NK) Cell Therapeutics Consumption Growth

5 Americas
5.1 Americas Natural Killer (NK) Cell Therapeutics Consumption by Countries
5.1.1 Americas Natural Killer (NK) Cell Therapeutics Consumption by Countries (2013-2018)
5.1.2 Americas Natural Killer (NK) Cell Therapeutics Value by Countries (2013-2018)
5.2 Americas Natural Killer (NK) Cell Therapeutics Consumption by Type
5.3 Americas Natural Killer (NK) Cell Therapeutics Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC
6.1 APAC Natural Killer (NK) Cell Therapeutics Consumption by Countries
6.1.1 APAC Natural Killer (NK) Cell Therapeutics Consumption by Countries (2013-2018)
6.1.2 APAC Natural Killer (NK) Cell Therapeutics Value by Countries (2013-2018)
6.2 APAC Natural Killer (NK) Cell Therapeutics Consumption by Type
6.3 APAC Natural Killer (NK) Cell Therapeutics Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 Europe
7.1 Europe Natural Killer (NK) Cell Therapeutics by Countries
7.1.1 Europe Natural Killer (NK) Cell Therapeutics Consumption by Countries (2013-2018)
7.1.2 Europe Natural Killer (NK) Cell Therapeutics Value by Countries (2013-2018)
7.2 Europe Natural Killer (NK) Cell Therapeutics Consumption by Type
7.3 Europe Natural Killer (NK) Cell Therapeutics Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa
8.1 Middle East & Africa Natural Killer (NK) Cell Therapeutics by Countries
8.1.1 Middle East & Africa Natural Killer (NK) Cell Therapeutics Consumption by Countries (2013-2018)
8.1.2 Middle East & Africa Natural Killer (NK) Cell Therapeutics Value by Countries (2013-2018)
8.2 Middle East & Africa Natural Killer (NK) Cell Therapeutics Consumption by Type
8.3 Middle East & Africa Natural Killer (NK) Cell Therapeutics Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.2 Natural Killer (NK) Cell Therapeutics Distributors
10.3 Natural Killer (NK) Cell Therapeutics Customer

11 Global Natural Killer (NK) Cell Therapeutics Market Forecast
11.1 Global Natural Killer (NK) Cell Therapeutics Consumption Forecast (2018-2023)
11.2 Global Natural Killer (NK) Cell Therapeutics Forecast by Regions
11.2.1 Global Natural Killer (NK) Cell Therapeutics Forecast by Regions (2018-2023)
11.2.2 Global Natural Killer (NK) Cell Therapeutics Value Forecast by Regions (2018-2023)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Natural Killer (NK) Cell Therapeutics Forecast by Type
11.8 Global Natural Killer (NK) Cell Therapeutics Forecast by Application

12 Key Players Analysis
12.1 Chipscreen Biosciences (China)
12.1.1 Company Details
12.1.2 Natural Killer (NK) Cell Therapeutics Product Offered
12.1.3 Chipscreen Biosciences (China) Natural Killer (NK) Cell Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
12.1.4 Main Business Overview
12.1.5 Chipscreen Biosciences (China) News
12.2 Affimed NV (Netherlands)
12.2.1 Company Details
12.2.2 Natural Killer (NK) Cell Therapeutics Product Offered
12.2.3 Affimed NV (Netherlands) Natural Killer (NK) Cell Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
12.2.4 Main Business Overview
12.2.5 Affimed NV (Netherlands) News
12.3 Altor BioScience Corporation (USA)
12.3.1 Company Details
12.3.2 Natural Killer (NK) Cell Therapeutics Product Offered
12.3.3 Altor BioScience Corporation (USA) Natural Killer (NK) Cell Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
12.3.4 Main Business Overview
12.3.5 Altor BioScience Corporation (USA) News
12.4 Innate Pharma SA (France)
12.4.1 Company Details
12.4.2 Natural Killer (NK) Cell Therapeutics Product Offered
12.4.3 Innate Pharma SA (France) Natural Killer (NK) Cell Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
12.4.4 Main Business Overview
12.4.5 Innate Pharma SA (France) News
12.5 Takeda Pharmaceutical (Japan)
12.5.1 Company Details
12.5.2 Natural Killer (NK) Cell Therapeutics Product Offered
12.5.3 Takeda Pharmaceutical (Japan) Natural Killer (NK) Cell Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
12.5.4 Main Business Overview
12.5.5 Takeda Pharmaceutical (Japan) News
12.6 Sorrento Therapeutics Inc. (USA)
12.6.1 Company Details
12.6.2 Natural Killer (NK) Cell Therapeutics Product Offered
12.6.3 Sorrento Therapeutics Inc. (USA) Natural Killer (NK) Cell Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
12.6.4 Main Business Overview
12.6.5 Sorrento Therapeutics Inc. (USA) News
12.7 NantKwest Inc. (USA)
12.7.1 Company Details
12.7.2 Natural Killer (NK) Cell Therapeutics Product Offered
12.7.3 NantKwest Inc. (USA) Natural Killer (NK) Cell Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
12.7.4 Main Business Overview
12.7.5 NantKwest Inc. (USA) News
12.8 Bristol-Myers Squibb (USA)
12.8.1 Company Details
12.8.2 Natural Killer (NK) Cell Therapeutics Product Offered
12.8.3 Bristol-Myers Squibb (USA) Natural Killer (NK) Cell Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
12.8.4 Main Business Overview
12.8.5 Bristol-Myers Squibb (USA) News
12.9 NKT Therapeutics (USA)
12.9.1 Company Details
12.9.2 Natural Killer (NK) Cell Therapeutics Product Offered
12.9.3 NKT Therapeutics (USA) Natural Killer (NK) Cell Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
12.9.4 Main Business Overview
12.9.5 NKT Therapeutics (USA) News

13 Research Findings and Conclusion
List of Tables and Figures_x000D_
_x000D_
Figure Picture of Natural Killer (NK) Cell Therapeutics_x000D_
Table Product Specifications of Natural Killer (NK) Cell Therapeutics_x000D_
Figure Natural Killer (NK) Cell Therapeutics Report Years Considered_x000D_
Figure Market Research Methodology_x000D_
Figure Global Natural Killer (NK) Cell Therapeutics Consumption Growth Rate 2013-2023 (K Units)_x000D_
Figure Global Natural Killer (NK) Cell Therapeutics Value Growth Rate 2013-2023 ($ Millions)_x000D_
Table Natural Killer (NK) Cell Therapeutics Consumption CAGR by Region 2013-2023 ($ Millions)_x000D_
Figure Product Picture of Mogamulizumab_x000D_
Table Major Players of Mogamulizumab_x000D_
Figure Product Picture of Lorvotuzumab Mertansine_x000D_
Table Major Players of Lorvotuzumab Mertansine_x000D_
Figure Product Picture of Others_x000D_
Table Major Players of Others_x000D_
Table Global Consumption Sales by Type (2013-2018)_x000D_
Table Global Natural Killer (NK) Cell Therapeutics Consumption Market Share by Type (2013-2018)_x000D_
Figure Global Natural Killer (NK) Cell Therapeutics Consumption Market Share by Type (2013-2018)_x000D_
Table Global Natural Killer (NK) Cell Therapeutics Revenue by Type (2013-2018) ($ million)_x000D_
Table Global Natural Killer (NK) Cell Therapeutics Value Market Share by Type (2013-2018) ($ Millions)_x000D_
Figure Global Natural Killer (NK) Cell Therapeutics Value Market Share by Type (2013-2018)_x000D_
Table Global Natural Killer (NK) Cell Therapeutics Sale Price by Type (2013-2018)_x000D_
Figure Natural Killer (NK) Cell Therapeutics Consumed in Cancer_x000D_
Figure Global Natural Killer (NK) Cell Therapeutics Market: Cancer (2013-2018) (K Units)_x000D_
Figure Global Natural Killer (NK) Cell Therapeutics Market: Cancer (2013-2018) ($ Millions)_x000D_
Figure Global Cancer YoY Growth ($ Millions)_x000D_
Figure Natural Killer (NK) Cell Therapeutics Consumed in Cardiovascular Diseases_x000D_
Figure Global Natural Killer (NK) Cell Therapeutics Market: Cardiovascular Diseases (2013-2018) (K Units)_x000D_
Figure Global Natural Killer (NK) Cell Therapeutics Market: Cardiovascular Diseases (2013-2018) ($ Millions)_x000D_
Figure Global Cardiovascular Diseases YoY Growth ($ Millions)_x000D_
Figure Natural Killer (NK) Cell Therapeutics Consumed in Others_x000D_
Figure Global Natural Killer (NK) Cell Therapeutics Market: Others (2013-2018) (K Units)_x000D_
Figure Global Natural Killer (NK) Cell Therapeutics Market: Others (2013-2018) ($ Millions)_x000D_
Figure Global Others YoY Growth ($ Millions)_x000D_
Table Global Consumption Sales by Application (2013-2018)_x000D_
Table Global Natural Killer (NK) Cell Therapeutics Consumption Market Share by Application (2013-2018)_x000D_
Figure Global Natural Killer (NK) Cell Therapeutics Consumption Market Share by Application (2013-2018)_x000D_
Table Global Natural Killer (NK) Cell Therapeutics Value by Application (2013-2018)_x000D_
Table Global Natural Killer (NK) Cell Therapeutics Value Market Share by Application (2013-2018)_x000D_
Figure Global Natural Killer (NK) Cell Therapeutics Value Market Share by Application (2013-2018)_x000D_
Table Global Natural Killer (NK) Cell Therapeutics Sale Price by Application (2013-2018)_x000D_
Table Global Natural Killer (NK) Cell Therapeutics Sales by Players (2016-2018) (K Units)_x000D_
Table Global Natural Killer (NK) Cell Therapeutics Sales Market Share by Players (2016-2018)_x000D_
Figure Global Natural Killer (NK) Cell Therapeutics Sales Market Share by Players in 2016_x000D_
Figure Global Natural Killer (NK) Cell Therapeutics Sales Market Share by Players in 2017_x000D_
Table Global Natural Killer (NK) Cell Therapeutics Revenue by Players (2016-2018) ($ Millions)_x000D_
Table Global Natural Killer (NK) Cell Therapeutics Revenue Market Share by Players (2016-2018)_x000D_
Figure Global Natural Killer (NK) Cell Therapeutics Revenue Market Share by Players in 2016_x000D_
Figure Global Natural Killer (NK) Cell Therapeutics Revenue Market Share by Players in 2017_x000D_
Table Global Natural Killer (NK) Cell Therapeutics Sale Price by Players (2016-2018)_x000D_
Figure Global Natural Killer (NK) Cell Therapeutics Sale Price by Players in 2017_x000D_
Table Global Natural Killer (NK) Cell Therapeutics Manufacturing Base Distribution and Sales Area by Players_x000D_
Table Players Natural Killer (NK) Cell Therapeutics Products Offered_x000D_
Table Natural Killer (NK) Cell Therapeutics Concentration Ratio (CR3, CR5 and CR10) (2016-2018)_x000D_
Table Global Natural Killer (NK) Cell Therapeutics Consumption by Regions 2013-2018 (K Units)_x000D_
Table Global Natural Killer (NK) Cell Therapeutics Consumption Market Share by Regions 2013-2018_x000D_
Figure Global Natural Killer (NK) Cell Therapeutics Consumption Market Share by Regions 2013-2018_x000D_
Table Global Natural Killer (NK) Cell Therapeutics Value by Regions 2013-2018 ($ Millions)_x000D_
Table Global Natural Killer (NK) Cell Therapeutics Value Market Share by Regions 2013-2018_x000D_
Figure Global Natural Killer (NK) Cell Therapeutics Value Market Share by Regions 2013-2018_x000D_
Figure Americas Natural Killer (NK) Cell Therapeutics Consumption 2013-2018 (K Units)_x000D_
Figure Americas Natural Killer (NK) Cell Therapeutics Value 2013-2018 ($ Millions)_x000D_
Figure APAC Natural Killer (NK) Cell Therapeutics Consumption 2013-2018 (K Units)_x000D_
Figure APAC Natural Killer (NK) Cell Therapeutics Value 2013-2018 ($ Millions)_x000D_
Figure Europe Natural Killer (NK) Cell Therapeutics Consumption 2013-2018 (K Units)_x000D_
Figure Europe Natural Killer (NK) Cell Therapeutics Value 2013-2018 ($ Millions)_x000D_
Figure Middle East & Africa Natural Killer (NK) Cell Therapeutics Consumption 2013-2018 (K Units)_x000D_
Figure Middle East & Africa Natural Killer (NK) Cell Therapeutics Value 2013-2018 ($ Millions)_x000D_
Table Americas Natural Killer (NK) Cell Therapeutics Consumption by Countries (2013-2018) (K Units)_x000D_
Table Americas Natural Killer (NK) Cell Therapeutics Consumption Market Share by Countries (2013-2018)_x000D_
Figure Americas Natural Killer (NK) Cell Therapeutics Consumption Market Share by Countries in 2017_x000D_
Table Americas Natural Killer (NK) Cell Therapeutics Value by Countries (2013-2018) ($ Millions)_x000D_
Table Americas Natural Killer (NK) Cell Therapeutics Value Market Share by Countries (2013-2018)_x000D_
Figure Americas Natural Killer (NK) Cell Therapeutics Value Market Share by Countries in 2017_x000D_
Table Americas Natural Killer (NK) Cell Therapeutics Consumption by Type (2013-2018) (K Units)_x000D_
Table Americas Natural Killer (NK) Cell Therapeutics Consumption Market Share by Type (2013-2018)_x000D_
Figure Americas Natural Killer (NK) Cell Therapeutics Consumption Market Share by Type in 2017_x000D_
Table Americas Natural Killer (NK) Cell Therapeutics Consumption by Application (2013-2018) (K Units)_x000D_
Table Americas Natural Killer (NK) Cell Therapeutics Consumption Market Share by Application (2013-2018)_x000D_
Figure Americas Natural Killer (NK) Cell Therapeutics Consumption Market Share by Application in 2017_x000D_
Figure United States Natural Killer (NK) Cell Therapeutics Consumption Growth 2013-2018 (K Units)_x000D_
Figure United States Natural Killer (NK) Cell Therapeutics Value Growth 2013-2018 ($ Millions)_x000D_
Figure Canada Natural Killer (NK) Cell Therapeutics Consumption Growth 2013-2018 (K Units)_x000D_
Figure Canada Natural Killer (NK) Cell Therapeutics Value Growth 2013-2018 ($ Millions)_x000D_
Figure Mexico Natural Killer (NK) Cell Therapeutics Consumption Growth 2013-2018 (K Units)_x000D_
Figure Mexico Natural Killer (NK) Cell Therapeutics Value Growth 2013-2018 ($ Millions)_x000D_
Table APAC Natural Killer (NK) Cell Therapeutics Consumption by Countries (2013-2018) (K Units)_x000D_
Table APAC Natural Killer (NK) Cell Therapeutics Consumption Market Share by Countries (2013-2018)_x000D_
Figure APAC Natural Killer (NK) Cell Therapeutics Consumption Market Share by Countries in 2017_x000D_
Table APAC Natural Killer (NK) Cell Therapeutics Value by Countries (2013-2018) ($ Millions)_x000D_
Table APAC Natural Killer (NK) Cell Therapeutics Value Market Share by Countries (2013-2018)_x000D_
Figure APAC Natural Killer (NK) Cell Therapeutics Value Market Share by Countries in 2017_x000D_
Table APAC Natural Killer (NK) Cell Therapeutics Consumption by Type (2013-2018) (K Units)_x000D_
Table APAC Natural Killer (NK) Cell Therapeutics Consumption Market Share by Type (2013-2018)_x000D_
Figure APAC Natural Killer (NK) Cell Therapeutics Consumption Market Share by Type in 2017_x000D_
Table APAC Natural Killer (NK) Cell Therapeutics Consumption by Application (2013-2018) (K Units)_x000D_
Table APAC Natural Killer (NK) Cell Therapeutics Consumption Market Share by Application (2013-2018)_x000D_
Figure APAC Natural Killer (NK) Cell Therapeutics Consumption Market Share by Application in 2017_x000D_
Figure China Natural Killer (NK) Cell Therapeutics Consumption Growth 2013-2018 (K Units)_x000D_
Figure China Natural Killer (NK) Cell Therapeutics Value Growth 2013-2018 ($ Millions)_x000D_
Figure Japan Natural Killer (NK) Cell Therapeutics Consumption Growth 2013-2018 (K Units)_x000D_
Figure Japan Natural Killer (NK) Cell Therapeutics Value Growth 2013-2018 ($ Millions)_x000D_
Figure Korea Natural Killer (NK) Cell Therapeutics Consumption Growth 2013-2018 (K Units)_x000D_
Figure Korea Natural Killer (NK) Cell Therapeutics Value Growth 2013-2018 ($ Millions)_x000D_
Figure Southeast Asia Natural Killer (NK) Cell Therapeutics Consumption Growth 2013-2018 (K Units)_x000D_
Figure Southeast Asia Natural Killer (NK) Cell Therapeutics Value Growth 2013-2018 ($ Millions)_x000D_
Figure India Natural Killer (NK) Cell Therapeutics Consumption Growth 2013-2018 (K Units)_x000D_
Figure India Natural Killer (NK) Cell Therapeutics Value Growth 2013-2018 ($ Millions)_x000D_
Figure Australia Natural Killer (NK) Cell Therapeutics Consumption Growth 2013-2018 (K Units)_x000D_
Figure Australia Natural Killer (NK) Cell Therapeutics Value Growth 2013-2018 ($ Millions)_x000D_
Table Europe Natural Killer (NK) Cell Therapeutics Consumption by Countries (2013-2018) (K Units)_x000D_
Table Europe Natural Killer (NK) Cell Therapeutics Consumption Market Share by Countries (2013-2018)_x000D_
Figure Europe Natural Killer (NK) Cell Therapeutics Consumption Market Share by Countries in 2017_x000D_
Table Europe Natural Killer (NK) Cell Therapeutics Value by Countries (2013-2018) ($ Millions)_x000D_
Table Europe Natural Killer (NK) Cell Therapeutics Value Market Share by Countries (2013-2018)_x000D_
Figure Europe Natural Killer (NK) Cell Therapeutics Value Market Share by Countries in 2017_x000D_
Table Europe Natural Killer (NK) Cell Therapeutics Consumption by Type (2013-2018) (K Units)_x000D_
Table Europe Natural Killer (NK) Cell Therapeutics Consumption Market Share by Type (2013-2018)_x000D_
Figure Europe Natural Killer (NK) Cell Therapeutics Consumption Market Share by Type in 2017_x000D_
Table Europe Natural Killer (NK) Cell Therapeutics Consumption by Application (2013-2018) (K Units)_x000D_
Table Europe Natural Killer (NK) Cell Therapeutics Consumption Market Share by Application (2013-2018)_x000D_
Figure Europe Natural Killer (NK) Cell Therapeutics Consumption Market Share by Application in 2017_x000D_
Figure Germany Natural Killer (NK) Cell Therapeutics Consumption Growth 2013-2018 (K Units)_x000D_
Figure Germany Natural Killer (NK) Cell Therapeutics Value Growth 2013-2018 ($ Millions)_x000D_
Figure France Natural Killer (NK) Cell Therapeutics Consumption Growth 2013-2018 (K Units)_x000D_
Figure France Natural Killer (NK) Cell Therapeutics Value Growth 2013-2018 ($ Millions)_x000D_
Figure UK Natural Killer (NK) Cell Therapeutics Consumption Growth 2013-2018 (K Units)_x000D_
Figure UK Natural Killer (NK) Cell Therapeutics Value Growth 2013-2018 ($ Millions)_x000D_
Figure Italy Natural Killer (NK) Cell Therapeutics Consumption Growth 2013-2018 (K Units)_x000D_
Figure Italy Natural Killer (NK) Cell Therapeutics Value Growth 2013-2018 ($ Millions)_x000D_
Figure Russia Natural Killer (NK) Cell Therapeutics Consumption Growth 2013-2018 (K Units)_x000D_
Figure Russia Natural Killer (NK) Cell Therapeutics Value Growth 2013-2018 ($ Millions)_x000D_
Figure Spain Natural Killer (NK) Cell Therapeutics Consumption Growth 2013-2018 (K Units)_x000D_
Figure Spain Natural Killer (NK) Cell Therapeutics Value Growth 2013-2018 ($ Millions)_x000D_
Table Middle East & Africa Natural Killer (NK) Cell Therapeutics Consumption by Countries (2013-2018) (K Units)_x000D_
Table Middle East & Africa Natural Killer (NK) Cell Therapeutics Consumption Market Share by Countries (2013-2018)_x000D_
Figure Middle East & Africa Natural Killer (NK) Cell Therapeutics Consumption Market Share by Countries in 2017_x000D_
Table Middle East & Africa Natural Killer (NK) Cell Therapeutics Value by Countries (2013-2018) ($ Millions)_x000D_
Table Middle East & Africa Natural Killer (NK) Cell Therapeutics Value Market Share by Countries (2013-2018)_x000D_
Figure Middle East & Africa Natural Killer (NK) Cell Therapeutics Value Market Share by Countries in 2017_x000D_
Table Middle East & Africa Natural Killer (NK) Cell Therapeutics Consumption by Type (2013-2018) (K Units)_x000D_
Table Middle East & Africa Natural Killer (NK) Cell Therapeutics Consumption Market Share by Type (2013-2018)_x000D_
Figure Middle East & Africa Natural Killer (NK) Cell Therapeutics Consumption Market Share by Type in 2017_x000D_
Table Middle East & Africa Natural Killer (NK) Cell Therapeutics Consumption by Application (2013-2018) (K Units)_x000D_
Table Middle East & Africa Natural Killer (NK) Cell Therapeutics Consumption Market Share by Application (2013-2018)_x000D_
Figure Middle East & Africa Natural Killer (NK) Cell Therapeutics Consumption Market Share by Application in 2017_x000D_
Figure Egypt Natural Killer (NK) Cell Therapeutics Consumption Growth 2013-2018 (K Units)_x000D_
Figure Egypt Natural Killer (NK) Cell Therapeutics Value Growth 2013-2018 ($ Millions)_x000D_
Figure South Africa Natural Killer (NK) Cell Therapeutics Consumption Growth 2013-2018 (K Units)_x000D_
Figure South Africa Natural Killer (NK) Cell Therapeutics Value Growth 2013-2018 ($ Millions)_x000D_
Figure Israel Natural Killer (NK) Cell Therapeutics Consumption Growth 2013-2018 (K Units)_x000D_
Figure Israel Natural Killer (NK) Cell Therapeutics Value Growth 2013-2018 ($ Millions)_x000D_
Figure Turkey Natural Killer (NK) Cell Therapeutics Consumption Growth 2013-2018 (K Units)_x000D_
Figure Turkey Natural Killer (NK) Cell Therapeutics Value Growth 2013-2018 ($ Millions)_x000D_
Figure GCC Countries Natural Killer (NK) Cell Therapeutics Consumption Growth 2013-2018 (K Units)_x000D_
Figure GCC Countries Natural Killer (NK) Cell Therapeutics Value Growth 2013-2018 ($ Millions)_x000D_
Table Natural Killer (NK) Cell Therapeutics Distributors List_x000D_
Table Natural Killer (NK) Cell Therapeutics Customer List_x000D_
Figure Global Natural Killer (NK) Cell Therapeutics Consumption Growth Rate Forecast (2018-2023) (K Units)_x000D_
Figure Global Natural Killer (NK) Cell Therapeutics Value Growth Rate Forecast (2018-2023) ($ Millions)_x000D_
Table Global Natural Killer (NK) Cell Therapeutics Consumption Forecast by Countries (2018-2023) (K Units)_x000D_
Table Global Natural Killer (NK) Cell Therapeutics Consumption Market Forecast by Regions_x000D_
Table Global Natural Killer (NK) Cell Therapeutics Value Forecast by Countries (2018-2023) ($ Millions)_x000D_
Table Global Natural Killer (NK) Cell Therapeutics Value Market Share Forecast by Regions_x000D_
Figure Americas Natural Killer (NK) Cell Therapeutics Consumption 2018-2023 (K Units)_x000D_
Figure Americas Natural Killer (NK) Cell Therapeutics Value 2018-2023 ($ Millions)_x000D_
Figure APAC Natural Killer (NK) Cell Therapeutics Consumption 2018-2023 (K Units)_x000D_
Figure APAC Natural Killer (NK) Cell Therapeutics Value 2018-2023 ($ Millions)_x000D_
Figure Europe Natural Killer (NK) Cell Therapeutics Consumption 2018-2023 (K Units)_x000D_
Figure Europe Natural Killer (NK) Cell Therapeutics Value 2018-2023 ($ Millions)_x000D_
Figure Middle East & Africa Natural Killer (NK) Cell Therapeutics Consumption 2018-2023 (K Units)_x000D_
Figure Middle East & Africa Natural Killer (NK) Cell Therapeutics Value 2018-2023 ($ Millions)_x000D_
Figure United States Natural Killer (NK) Cell Therapeutics Consumption 2018-2023 (K Units)_x000D_
Figure United States Natural Killer (NK) Cell Therapeutics Value 2018-2023 ($ Millions)_x000D_
Figure Canada Natural Killer (NK) Cell Therapeutics Consumption 2018-2023 (K Units)_x000D_
Figure Canada Natural Killer (NK) Cell Therapeutics Value 2018-2023 ($ Millions)_x000D_
Figure Mexico Natural Killer (NK) Cell Therapeutics Consumption 2018-2023 (K Units)_x000D_
Figure Mexico Natural Killer (NK) Cell Therapeutics Value 2018-2023 ($ Millions)_x000D_
Figure Brazil Natural Killer (NK) Cell Therapeutics Consumption 2018-2023 (K Units)_x000D_
Figure Brazil Natural Killer (NK) Cell Therapeutics Value 2018-2023 ($ Millions)_x000D_
Figure China Natural Killer (NK) Cell Therapeutics Consumption 2018-2023 (K Units)_x000D_
Figure China Natural Killer (NK) Cell Therapeutics Value 2018-2023 ($ Millions)_x000D_
Figure Japan Natural Killer (NK) Cell Therapeutics Consumption 2018-2023 (K Units)_x000D_
Figure Japan Natural Killer (NK) Cell Therapeutics Value 2018-2023 ($ Millions)_x000D_
Figure Korea Natural Killer (NK) Cell Therapeutics Consumption 2018-2023 (K Units)_x000D_
Figure Korea Natural Killer (NK) Cell Therapeutics Value 2018-2023 ($ Millions)_x000D_
Figure Southeast Asia Natural Killer (NK) Cell Therapeutics Consumption 2018-2023 (K Units)_x000D_
Figure Southeast Asia Natural Killer (NK) Cell Therapeutics Value 2018-2023 ($ Millions)_x000D_
Figure India Natural Killer (NK) Cell Therapeutics Consumption 2018-2023 (K Units)_x000D_
Figure India Natural Killer (NK) Cell Therapeutics Value 2018-2023 ($ Millions)_x000D_
Figure Australia Natural Killer (NK) Cell Therapeutics Consumption 2018-2023 (K Units)_x000D_
Figure Australia Natural Killer (NK) Cell Therapeutics Value 2018-2023 ($ Millions)_x000D_
Figure Germany Natural Killer (NK) Cell Therapeutics Consumption 2018-2023 (K Units)_x000D_
Figure Germany Natural Killer (NK) Cell Therapeutics Value 2018-2023 ($ Millions)_x000D_
Figure France Natural Killer (NK) Cell Therapeutics Consumption 2018-2023 (K Units)_x000D_
Figure France Natural Killer (NK) Cell Therapeutics Value 2018-2023 ($ Millions)_x000D_
Figure UK Natural Killer (NK) Cell Therapeutics Consumption 2018-2023 (K Units)_x000D_
Figure UK Natural Killer (NK) Cell Therapeutics Value 2018-2023 ($ Millions)_x000D_
Figure Italy Natural Killer (NK) Cell Therapeutics Consumption 2018-2023 (K Units)_x000D_
Figure Italy Natural Killer (NK) Cell Therapeutics Value 2018-2023 ($ Millions)_x000D_
Figure Russia Natural Killer (NK) Cell Therapeutics Consumption 2018-2023 (K Units)_x000D_
Figure Russia Natural Killer (NK) Cell Therapeutics Value 2018-2023 ($ Millions)_x000D_
Figure Spain Natural Killer (NK) Cell Therapeutics Consumption 2018-2023 (K Units)_x000D_
Figure Spain Natural Killer (NK) Cell Therapeutics Value 2018-2023 ($ Millions)_x000D_
Figure Egypt Natural Killer (NK) Cell Therapeutics Consumption 2018-2023 (K Units)_x000D_
Figure Egypt Natural Killer (NK) Cell Therapeutics Value 2018-2023 ($ Millions)_x000D_
Figure South Africa Natural Killer (NK) Cell Therapeutics Consumption 2018-2023 (K Units)_x000D_
Figure South Africa Natural Killer (NK) Cell Therapeutics Value 2018-2023 ($ Millions)_x000D_
Figure Israel Natural Killer (NK) Cell Therapeutics Consumption 2018-2023 (K Units)_x000D_
Figure Israel Natural Killer (NK) Cell Therapeutics Value 2018-2023 ($ Millions)_x000D_
Figure Turkey Natural Killer (NK) Cell Therapeutics Consumption 2018-2023 (K Units)_x000D_
Figure Turkey Natural Killer (NK) Cell Therapeutics Value 2018-2023 ($ Millions)_x000D_
Figure GCC Countries Natural Killer (NK) Cell Therapeutics Consumption 2018-2023 (K Units)_x000D_
Figure GCC Countries Natural Killer (NK) Cell Therapeutics Value 2018-2023 ($ Millions)_x000D_
Table Global Natural Killer (NK) Cell Therapeutics Consumption Forecast by Type (2018-2023) (K Units)_x000D_
Table Global Natural Killer (NK) Cell Therapeutics Consumption Market Share Forecast by Type (2018-2023)_x000D_
Table Global Natural Killer (NK) Cell Therapeutics Value Forecast by Type (2018-2023) ($ Millions)_x000D_
Table Global Natural Killer (NK) Cell Therapeutics Value Market Share Forecast by Type (2018-2023)_x000D_
Table Global Natural Killer (NK) Cell Therapeutics Consumption Forecast by Application (2018-2023) (K Units)_x000D_
Table Global Natural Killer (NK) Cell Therapeutics Consumption Market Share Forecast by Application (2018-2023)_x000D_
Table Global Natural Killer (NK) Cell Therapeutics Value Forecast by Application (2018-2023) ($ Millions)_x000D_
Table Global Natural Killer (NK) Cell Therapeutics Value Market Share Forecast by Application (2018-2023)_x000D_
Table Chipscreen Biosciences (China) Basic Information, Manufacturing Base, Sales Area and Its Competitors_x000D_
Table Chipscreen Biosciences (China) Natural Killer (NK) Cell Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)_x000D_
Figure Chipscreen Biosciences (China) Natural Killer (NK) Cell Therapeutics Market Share (2016-2018)_x000D_
Table Affimed NV (Netherlands) Basic Information, Manufacturing Base, Sales Area and Its Competitors_x000D_
Table Affimed NV (Netherlands) Natural Killer (NK) Cell Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)_x000D_
Figure Affimed NV (Netherlands) Natural Killer (NK) Cell Therapeutics Market Share (2016-2018)_x000D_
Table Altor BioScience Corporation (USA) Basic Information, Manufacturing Base, Sales Area and Its Competitors_x000D_
Table Altor BioScience Corporation (USA) Natural Killer (NK) Cell Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)_x000D_
Figure Altor BioScience Corporation (USA) Natural Killer (NK) Cell Therapeutics Market Share (2016-2018)_x000D_
Table Innate Pharma SA (France) Basic Information, Manufacturing Base, Sales Area and Its Competitors_x000D_
Table Innate Pharma SA (France) Natural Killer (NK) Cell Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)_x000D_
Figure Innate Pharma SA (France) Natural Killer (NK) Cell Therapeutics Market Share (2016-2018)_x000D_
Table Takeda Pharmaceutical (Japan) Basic Information, Manufacturing Base, Sales Area and Its Competitors_x000D_
Table Takeda Pharmaceutical (Japan) Natural Killer (NK) Cell Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)_x000D_
Figure Takeda Pharmaceutical (Japan) Natural Killer (NK) Cell Therapeutics Market Share (2016-2018)_x000D_
Table Sorrento Therapeutics Inc. (USA) Basic Information, Manufacturing Base, Sales Area and Its Competitors_x000D_
Table Sorrento Therapeutics Inc. (USA) Natural Killer (NK) Cell Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)_x000D_
Figure Sorrento Therapeutics Inc. (USA) Natural Killer (NK) Cell Therapeutics Market Share (2016-2018)_x000D_
Table NantKwest Inc. (USA) Basic Information, Manufacturing Base, Sales Area and Its Competitors_x000D_
Table NantKwest Inc. (USA) Natural Killer (NK) Cell Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)_x000D_
Figure NantKwest Inc. (USA) Natural Killer (NK) Cell Therapeutics Market Share (2016-2018)_x000D_
Table Bristol-Myers Squibb (USA) Basic Information, Manufacturing Base, Sales Area and Its Competitors_x000D_
Table Bristol-Myers Squibb (USA) Natural Killer (NK) Cell Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)_x000D_
Figure Bristol-Myers Squibb (USA) Natural Killer (NK) Cell Therapeutics Market Share (2016-2018)_x000D_
Table NKT Therapeutics (USA) Basic Information, Manufacturing Base, Sales Area and Its Competitors_x000D_
Table NKT Therapeutics (USA) Natural Killer (NK) Cell Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)_x000D_
Figure NKT Therapeutics (USA) Natural Killer (NK) Cell Therapeutics Market Share (2016-2018)_x000D_

Get Free Sample

You can get a FREE sample of any report. Just click the "Free Sample" link.

Explore Latest Reports

If you have any special requirement or looking for more discounts, Kindly contact our sales team

Contact Us